INTERACTION OF PHE(8) OF ANGIOTENSIN-II WITH LYS(199) AND HIS(256) OF AT(1) RECEPTOR IN AGONIST ACTIVATION

被引:115
作者
NODA, K [1 ]
SAAD, Y [1 ]
KARNIK, SS [1 ]
机构
[1] CLEVELAND CLIN FDN,RES INST,DEPT MOLEC CARDIOL,CLEVELAND,OH 44195
关键词
D O I
10.1074/jbc.270.48.28511
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
The acidic pharmacophores of selective ligands bind to Lys(199) and His(256) of the AT(1) receptor (Noda, K., Saad, Y., Kinoshita, A., Boyle, T. P., Graham, R. M., Husain, A., and Karnik, S. (1995) J. Biol. Chem. 270, 2284-2289). In this report we examine how interactions between these residues and agonists activate inositol phosphate production in transiently transfected COS-1 cells, [Sar(1)] angiotensin (Ang II) II and [Sar(1)]Ang II-amide stimulated a 5-fold inositol phosphate response from wild-type AT(1) receptor. The peptide antagonist [Sar(1),Ile(8)]Ang II and the non-peptide agonist L-162,313 produced a partial but saturating response. Stimulation of wild-type receptor by [Sar(1)]Ang II-amide and the mutant K199Q and K199A receptors by [Sar(1)]Ang II demonstrates that AT(1) receptor activation is not critically dependent on the ion-pairing of the alpha-COOH group of Ang II with Lys(199). The mutation of His(256) produced diminished inositol phosphate response without commensurate change in binding affinity of ligands. The His(256) Side chain is critical for maximal activation of the AT(1) receptor, although isosteric Gln substitution is sufficient for preserving the affinity for Phe(8)-substituted analogues of [Sar(1)]Ang II. Therefore, AT(1) receptor activation requires interaction of Phe(8) side chain of Ang II with His(256), which is achieved by docking the alpha-COOH group of Phe(8) to Lys(199). Furthermore, non-peptide agonists interact with Lys(199) and His(256) in a similar fashion.
引用
收藏
页码:28511 / 28514
页数:4
相关论文
共 20 条
[1]   STUDIES ON ANGIOTENSIN-II AND ANALOGS - IMPACT OF SUBSTITUTION IN POSITION-8 ON CONFORMATION AND ACTIVITY [J].
AUMELAS, A ;
SAKARELLOS, C ;
LINTNER, K ;
FERMANDJIAN, S ;
KHOSLA, MC ;
SMEBY, RR ;
BUMPUS, FM .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1985, 82 (07) :1881-1885
[2]   MUTATION OF ASP(74) OF THE RAT ANGIOTENSIN-II RECEPTOR CONFERS CHANGES IN ANTAGONIST AFFINITIES AND ABOLISHES G-PROTEIN COUPLING [J].
BIHOREAU, C ;
MONNOT, C ;
DAVIES, E ;
TEUTSCH, B ;
BERNSTEIN, KE ;
CORVOL, P ;
CLAUSER, E .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1993, 90 (11) :5133-5137
[3]  
BUMPUS FM, 1977, HYPERTENSION PHYSIOP, P183
[4]  
CHENG Y, 1973, BIOCHEM PHARMACOL, V22, P3099
[5]  
Creighton T. E., 1984, PROTEINS STRUCTURES, V2nd
[6]   THE DOCKING OF ARG(2) OF ANGIOTENSIN-II WITH ASP(2) RECEPTOR IS ESSENTIAL FOR FULL AGONISM [J].
FENG, YH ;
NODA, K ;
SAAD, Y ;
LIU, XP ;
HUSAIN, A ;
KARNIK, SS .
JOURNAL OF BIOLOGICAL CHEMISTRY, 1995, 270 (21) :12846-12850
[7]  
HJORTH SA, 1994, J BIOL CHEM, V269, P30953
[8]   ROLE OF THE C-TERMINAL CARBOXYLATE IN ANGIOTENSIN-II ACTIVITY - ALCOHOL, KETONE, AND ESTER ANALOGS OF ANGIOTENSIN-II [J].
HSIEH, KH ;
MARSHALL, GR .
JOURNAL OF MEDICINAL CHEMISTRY, 1986, 29 (10) :1968-1971
[9]  
HUSAIN A, 1986, J PHARMACOL EXP THER, V239, P71
[10]  
JI H, 1994, J BIOL CHEM, V269, P16533